YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

FDA gives green light to new schizophrenia drug

Posted online

The Food and Drug Administration has approved a new schizophrenia drug from Bristol Myers Squibb.

Called Cobenfy, the drug is the first novel type of treatment for the mental disorder in more than seven decades, according to CNBC.

Bristol Myers Squibb expects the twice-daily pill to become available in October.

Read more from CNBC.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Annual downtown holiday events combine for Nov. 21 celebration

Organizers hope to bolster client traffic to center city businesses.

Most Read
SBJ.net Poll
How often do you use artificial intelligence for your business?

*

View results

Update cookies preferences